Eve T. Rodler

Cancer-Related Fatigue

Ann M. Berger, Amy Pickar Abernethy, Ashley Atkinson et al. · Journal of the National Comprehensive Cancer Network · 2010 · 274 citations · Full text

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga et al. · Journal of Clinical Oncology · 2021 · 131 citations · Full text

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Seth M. Pollack, Achim A. Jungbluth, Benjamin Hoch et al. · Cancer · 2012 · 120 citations

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <i>BRCA</i> Mutation–Associated Breast Cancer

Eve T. Rodler, Brenda F. Kurland, Melissa Griffin et al. · Clinical Cancer Research · 2016 · 97 citations · Full text

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

Eve T. Rodler, Priyanka Sharma, William E. Barlow et al. · The Lancet Oncology · 2023 · 92 citations · Full text

Breast Oncology, Medicine, Pharmacology +6